SBI works with scientists to commercialize their technologies through licensing and other programs.

Have you recently developed an exciting technique in your lab and thought, “I bet this would make a great kit!” Or, “It’s not quite CRISPR, but other scientists could really use this—how can I get this technology out there?” Or even, “if I could commercialize this I might actually be able to afford to live in this hi-tech hotbed on a scientist’s salary.”

If so, you’re not alone. More and more academic scientists are looking to commercialize methods and techniques developed in their labs, and many are not quite sure where to begin and/or are not ready to give up their highly-rewarding day-to-day research projects. One way to bridge the gap is to license out your technology to a company like SBI. We are always on the lookout for the latest life science advances that speed and simplify how scientists get their research done.

For example, take a look at our recently developed CLOuD9 Gene Expression Regulation System. Not only did we license this technology, our scientists shared their expertise with CRISPR/Cas9 to get this technology off the ground. And there’s a nice Nature Communications paper, too1.

Minicircles are another example, and show how you can set up the licensing to enable access to not-for-profit researchers while staying in control of how for-profit organizations use your technology.

Helping academic researchers commercialize their work is one way SBI is able to deliver the most recent, cutting edge technologies. So be sure to reach out to us if you have a technology you’d like commercialize—visit our Contact page, choose “Partnership” in the “Attention” dropdown menu, and tell us more.


  1. Morgan, et al. Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping. Nat Commun. 2017; 8: 15993. PMCID: PMC5511349.